A quarter of people with HCV initially refused access to sofosbuvir/lepidasvir

A quarter of people with HCV initially refused access to sofosbuvir/lepidasvir
Treatment of HCV infection has been revolutionised by the development of direct-acting antiviral (DDA) agents. Compared to traditional therapy with pegylated interferon/ribavirin, treatment with DDAs is associated with better tolerability, improved …
Read more here.

Seattle Baby Boomers: You're At Risk For Hepatitis C
“Some of it is because there were lots of behaviors that happened in young people during those years that could've potentially led to blood-borne exposures through experimentation with drugs or exposure to blood before blood was screened for hepatitis C.”.
Read more here.
This Is Why Hepatitis C Drugs Are So Expensive
For 75 to 85 percent of those people, infection will lead to chronic hepatitis-related diseases like liver cancer, cirrhosis or liver disease. In fact, hepatitis C is the most common reason people have liver transplants in the U.S. And the new, better …
Read more here.

Cloud Of Uncertainty Has Been Covering Gilead Over The Past Year But That's
The truth of the matter is that the company offers up rebates for the Hep C treatments and there is no real competitor out there going against Harvoni or Sovaldi as they are cures and the other medication out there are just treatments. Just ask any …
Read more here.
Biocon soars 7% on drug launch
BENGALURU: Biopharmaceutical company Biocon on Thursday said it has launched a generic version of Gilead Sciences' Hepatitis C drug, Harvoni, in India. Shares of India's largest biotechnology company zoomed 6.5% after the announcement to touch a …
Read more here.

Sofosbuvir/daclatasvir combination could be produced for 0 per hepatitis C cure
Month-by-month tracking of the prices paid in India for the chemicals used to make hepatitis C direct-acting antivirals shows that it is now possible to make and sell a combination of drugs to cure hepatitis C for less than $ 200, Dr Andrew Hill of …
Read more here.
Actress Pamela Anderson Cures Hepatitis C With Antiviral Medication: Why
There are also come groups of people at increased risk for hep C: people who use drugs, people who have undergone invasive healthcare procedures with inadequate safety practices, and people, like Anderson, who have had tattoos and piercings.
Read more here.

Enanta Pharmaceuticals Announces FDA Acceptance of AbbVie's New Drug
VIEKIRA PAK® (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets) is a prescription medicine used with or without ribavirin to treat adults with genotype 1 chronic (lasting a long time) hepatitis C (hep C) virus infection, including …
Read more here.
High Cost of Our Medications and What Can Be Done About It
CMS attributes this to speciality medications such as those that treat hepatitis C. It is estimated that bringing a new drug to market will cost 2.6 billion and more than 10 years. Some of the newer medications target specific mutations or specific …
Read more here.

Hepatitis C drugs Sovaldi and Harvoni out of reach for most, except inmates
Jane Blumenfeld was diagnosed with hepatitis C more than a decade ago. Her insurance company, Anthem Blue Cross, will not approve a prescription for Harvoni, which could cure her of the disease, saying the drug is too expensive. Photo by Michael Baker.
Read more here.
How 2015 became the year of prescription drug price outrage
Around the industry, drugmakers slapped big prices on new drugs. The cost of branded drugs outpaced inflation for the 10th consecutive year, and spending on complex specialty drugs, like those for cancer and hepatitis C, increased nearly 27 percent, …
Read more here.

Top 10 Medicines of 2015
Sovaldi's appearance is also significant because the number of prescriptions written for it is much lower than the other drugs on this list—a likely consequence of the cost-benefit debate about hepatitis C drugs. Only 164,576 prescriptions have been …
Read more here.


Leave a Reply